Other GH secretagogues / GHRPs
Muscle & Strength · GH secretagogue / ghrelin receptor agonist
Tier D+
What this is
WADA coverage: growth hormone secretagogues/GHS, anamorelin, capromorelin, macimorelin, tabimorelin, GH-releasing peptides/GHRPs, alexamorelin, examorelin/hexarelin, GHRP-1, GHRP-3, GHRP-4 and GHRP-5. Existing rows cover MK-677, ipamorelin and GHRP-2/GHRP-6. Additional WADA alias coverage: CJC-1293.
Mechanism
Ghrelin-receptor agonists and GHRPs stimulate pulsatile GH release; gray-market use aims at recovery, sleep, appetite, fat loss and lean-mass effects.
Dose & route
No approved enhancement dose; diagnostic/clinical dosing varies by agent
Citations
Links go to the source. If a link is dead or you want something re-checked, let me know.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.